Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion type Assertion NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_head.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion description "[Elevated pretreatment levels of hTERT were identified in 80.2% of squamous cell carcinoma and 73.8% of adenocarcinoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion evidence source_evidence_literature NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion SIO_000772 21319134 NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion wasDerivedFrom befree-20140225 NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.
- NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_assertion wasGeneratedBy ECO_0000203 NP600752.RAfdjOrGIav8tGHY0kQuMUagWUPEoAtSw_qdmdjOz0gdM130_provenance.